Today, we hear from Dr. Matthew R. McKay, a professor in the Department of Electronics and Computer Engineering as well as the Department of Chemical and Biological Engineering at the Hong Kong University of Science and Technology. In this episode, we discuss Dr. McKay's paper published in the journal Viruses titled, "Preliminary Identification of Potential Vaccine Targets or the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies".

Thanks for joining us for this wonderful opportunity to learn from one of the leading researchers on the COVID pandemic. Enjoy!

Talking Points:

• About this podcast and our mission (0:00)
• Dr. McKay discusses his findings in his paper on vaccine targets (1:42)
• Results on COVID-19 and SARS epitopes (4:42)
• Progress on treatment for COVID-19 (5:27)
• Differences in the vaccine development for SARS and COVID (6:52)
• The reality of starting from scratch in COVID-19 vaccine development (7:45)
• The trial process of vaccine development (9:05)
• Antibody-dependent enhancement (10:16)
• Final thoughts (11:15)

Resources: "Preliminary Identification of Potential Vaccine Targets or the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies" Viruses. 2020 Feb 25. https://pubmed.ncbi.nlm.nih.gov/32106567/